Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
The surprising part is that Gilead's shares slumped last month despite the late-stage success of its next major HIV single-tablet drug regimen: a fixed-dose combination of bictegravir and emtricitabine/tenofovir alafenamide indicated for the …
Investors have turned to the pharmaceutical industry for solid dividend stocks for a long time. However, biotechs typically weren't high on the list when it came to dividends. Over the past few years, though, Amgen, Inc. (NASDAQ: AMGN) …
Shares of Gilead Sciences, Inc. closed the previous trading session at 73.74 down -0.65 -0.87% with 8,910,934 shares …
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one high-profile Wall Street pick and putting it …
Israel "Izzy" Englander has made plenty of smart stock picks during his career. The co-founder of the Millennium Management hedge fund is worth more than $5 billion as a result. Millennium Management bought another 480,000 …
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Robin L. Washington, Gilead’s Executive Vice President …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
Yahoo!10mon